The Indian Council of Medical Research (ICMR) is conducting an inquiry into a reaction to AstraZeneca’s COVID-19 vaccine trial. A senior official at AstraZeneca told Reuters on Sunday that even after the adverse effects, there is no reason to halt the trials.

India: AstraZeneca vaccine causes adverse reaction in volunteer, inquiry underway

In a 1988 essay on pandemics, Joshua Lederberg, Nobel laureate and president of The Rockefeller University, reminded the medical community that when it comes to infectious disease, the laws of Darwin are as important as the vaccines of Pasteur.

The virus won’t stop evolving when the vaccine arrives

Prime Minister Narendra Modi on Saturday concluded his visit to Zydus Biotech Park in Ahmedabad after reviewing the development of COVID-19 vaccine candidate ZyCOV-D.

PM Modi concludes Zydus Biotech Park visit, next stop Bharat Biotech facility in Hyderabad

Preliminary results on the AstraZeneca vaccine were based on a total of 131 COVID-19 cases in a study involving 11,636 participants.

AstraZeneca defends dosing error in covid-19 vaccine trial

WION Fineprint: How did a smaller dose prove more effective?

Several foreign envoys will be visiting Pune on December 4 to see India's covid vaccine development programme. The visit, organized by India's Ministry of External Affairs will be a one-day visit.

Foreign envoys to visit Pune on Dec 4 to see India's COVID-19 vaccine programme

Sweden`s Recipharm will produce doses of Moderna`s COVID-19 vaccine candidate in central France, the company said on Wednesday, adding it had started recruiting and investing to start manufacturing.

Recipharm to produce some of Moderna's COVID-19 vaccine in France

The race for a coronavirus vaccine has stoked a debate on how much the jabs will cost and who will pay for them, as prices range from $10 to $40 per person. An affordable price for the coronavirus vaccine can very well act as the deciding factor in the purchase and sale of a particular brand and its profit.

Coronavirus vaccine: How price plays an extremely crucial role

Hopes over Covid-19 vaccines have given a boost to virus-weary citizens across the globe in recent days, but the disease remains rampant and world leaders are urging people to be patient.

From production to distribution: Comprehensive guide to coronavirus vaccine

If you are planning to fly back home from Australia's Qantas Airways in the year 2021, then we would suggest scheduling your flight after a vaccine shot as the airways has decided to not let people board the flight if they are not vaccinated against COVID-19.

No fly list: Qantas Airways makes COVID vaccine necessary for international flights

The Serum Institute of India, the world`s largest manufacturer of vaccines by volume, will first focus on supplying AstraZeneca Plc`s COVID-19 vaccine to Indians before distributing it to other countries, Serum`s Chief Executive Adar Poonawalla said on Monday.

Serum Institute to focus on supplying COVID-19 vaccine to India first

Reacting on the pricing of two coronavirus vaccine candidates Pfizer and Moderna that has recently shown encouraging results from their human trials, Russia's Sputnik V has said that its prices would be "much lower".

Sputnik V takes a jibe at Pfizer, Moderna Covid-19 vaccine prices, claims own drug much cheaper

Prime Minister Narendra Modi is likely to hold virtual meetings with chief ministers and other representatives of states and union territories on Tuesday to review the COVID-19 situation and discuss vaccine distribution strategy.

PM Modi likely to hold virtual meetings with states over Covid-19 situation, vaccine distribution plan

“Our vaccine, therefore, costs about the same as a flu shot, which is between $10 and $50,” he was quoted as saying.

Moderna to charge $25-$37 for COVID-19 vaccine, says CEO

India's pharmaceutical company Bharat Biotech International Ltd has now, months later, revealed that during Phase 1 of the human trial of COVID-19 vaccine, the company had an adverse event.

Bharat Biotech reveals adverse event during Phase 1 trial of COVID-19 vaccine

A substantial part of the Spanish population will be vaccinated against COVID-19 in the first half of 2021, Prime Minister Pedro Sanchez said on Friday, highlighting also a steadily slowing pace of contagion after restrictions imposed in recent weeks.

Spain eyes 'substantial' vaccination in first half 2021, contagion slows

With 45,882 new COVID-19 infections, India COVID-19 caseload surged above the 90-lakh mark on Friday. According to the Health Ministry's Friday morning update, the total caseload in the country has risen to 90,04,366.

India's COVID-19 cases top 90 lakh; active cases at 4.43 lakh

India is racing ahead with work on its coronavirus vaccine as countries around the world sought to conquer the pandemic and rescue their economies. Also read: These three Indian companies are ready to produce Covid-19 vaccine Companies like Zydus Cadila, Serum Institute and Bharat Biotech are at the forefront of research on covid vaccines and are likely to be among the leading manufacturers as and when their commercial application is permitted.

Oxford COVID-19 vaccine to be available for Indians by April 2021: Serum Institute Chief 

Pfizer and its partner BioNTech confirmed on Friday they have applied to US health regulators for emergency use authorisation (EUA) of its COVID-19 vaccine, becoming the first to do so in the US as the pandemic rages around the world.

Pfizer, BioNTech apply for emergency use of coronavirus vaccine in US

India's wait for COVID-19 vaccine is soon to be over. The Indian Health Minister Harsh Vardhan has announced that India is set to get the much waited COVID-19 vaccine early next year.

India will get COVID-19 vaccine by early 2021: Harsh Vardhan

Union Health and Family Welfare Minister Dr Harsh Vardhan on Thursday said he was confident that the COVID-19 vaccine would be ready in the next three-four months and added that the priority to provide the same to 135 crore Indians would be based on scientific evaluation.

Confident that Covid-19 vaccine will be ready in 3-4 months: India's health minister

Foreign brokerage Goldman Sachs on Tuesday upgraded its India GDP forecast to a contraction of 10.3 per cent in FY21, as against its earlier estimate of a negative growth of 14.

Goldman Sachs ups India's eco forecast on vaccine progress, now expects 10.8 pc contraction in FY21

A team of scientists have recently revealed that a range of chemicals found in daily-use products could hinder the effectiveness and success of the COVID-19 vaccine.

Chemicals found in daily-use products could decrease COVID-19 vaccine's effectiveness: Reports

Moderna Inc said on Monday (November 16) its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage clinical trial, becoming the second U.S. company in a week to report results that far exceed expectations.

Moderna says coronavirus vaccine 94.5% effective

covid-19-vaccine

Covid 19 Vaccine, News on Covid 19 Vaccine, stories on Covid 19 Vaccine, articles on Covid 19 Vaccine, Covid 19 Vaccine stories at Wion, Covid 19 Vaccine news, Covid 19 Vaccine latest news

covid 19-vaccine